MedPath

A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients

Not Applicable
Completed
Conditions
Coronary Artery Disease
Interventions
Device: Medtronic Resolute Onyx Zotarolimus-Eluting Coronary Stent System
Device: Biosensors BioFreedom BA9 Drug Coated Coronary Stent
Registration Number
NCT03344653
Lead Sponsor
Medtronic Vascular
Brief Summary

The purpose of this study is to evaluate the clinical safety and effectiveness of the Resolute Onyx stent in subjects deemed at high risk for bleeding and/or medically unsuitable for more than 1 month DAPT treatment receiving reduced duration (1 month) of DAPT following stent implantation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2000
Inclusion Criteria
  • Age ≥ 75 years old
  • Any prior documented intracerebral bleed
  • Any documented stroke in the last 12 months
  • Hospital admission for bleeding during the prior 12 months
  • Non-skin cancer diagnosed or treated ≤3 years
  • Planned surgery within the next 12 months
  • Renal failure defined as: Creatinine clearance <40 ml/min
  • Thrombocytopenia (PLT <100,000/mm3)
  • Severe chronic liver disease defined as: subjects who have developed any of the following: variceal hemorrhage, ascites, hepatic encephalopathy or jaundice
Exclusion Criteria
  • Pregnant and breastfeeding women
  • Subjects requiring a planned PCI procedure after 1 month of index procedure
  • Active bleeding at the time of inclusion
  • Cardiogenic shock
  • A known hypersensitivity or contraindication to aspirin, heparin and bivalirudin, P2Y12 inhibitors, mTOR inhibiting drugs such as zotarolimus, Biolimus A9 (or its derivatives), cobalt, nickel, platinum, iridium, chromium, molybdenum, polymer coatings (eg, BioLinx™), stainless steel (or other metal ions found in 316L stainless steel), zinc, or a sensitivity to contrast media, which cannot be adequately pre-medicated.
  • PCI during the previous 6 months for a lesion other than the target lesion of the index procedure
  • Participation in another clinical study within 12 months after index procedure
  • Subjects with life expectancy of less than 2 years

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Resolute Onyx stentMedtronic Resolute Onyx Zotarolimus-Eluting Coronary Stent SystemSubjects who fulfill the inclusion criteria and none of the exclusion criteria will be randomly allocated in a 1:1 fashion to treatment with a Resolute Onyx stent or the BioFreedom stent followed by 1-month DAPT. Subjects implanted with the Resolute Onyx stent will be assessed for non-inferiority compared to those implanted with the BioFreedom stent using a composite safety endpoint of cardiac death, myocardial infarction, and definite/probable stent thrombosis, at 1 year post-procedure.
BioFreedom stentBiosensors BioFreedom BA9 Drug Coated Coronary StentSubjects who fulfill the inclusion criteria and none of the exclusion criteria will be randomly allocated in a 1:1 fashion to treatment with a Resolute Onyx stent or the BioFreedom stent followed by 1-month DAPT. Subjects implanted with the Resolute Onyx stent will be assessed for non-inferiority compared to those implanted with the BioFreedom stent using a composite safety endpoint of cardiac death, myocardial infarction, and definite/probable stent thrombosis, at 1 year post-procedure.
Primary Outcome Measures
NameTimeMethod
Composite endpoint: Cardiac Death, Myocardial Infarction, or Stent Thrombosis1 year post-procedure

Powered for non-inferiority against BioFreedom (control), is a composite of cardiac death, myocardial infarction and definite/probable stent thrombosis. The combined clinical outcome of cardiac death, MI or stent thrombosis

Secondary Outcome Measures
NameTimeMethod
Major Cardiac Event2 year post- procedure

Major adverse cardiac event (MACE) defined as composite of death, myocardial infarction, or repeat target lesion revascularization (clinically driven) by percutaneous or surgical methods

Target Vessel Failure2 year post-procedure

Target vessel failure (TVF) defined as composite of cardiac death, target vessel myocardial infarction, or clinically-driven target vessel revascularization (TVR) by percutaneous or surgical methods.

Cardiac Death2 year post- procedure

All deaths including cardiac death

Myocardial Infarction2 year post-procedure

All myocardial infarction including Target Vessel Myocardial Infarction (TVMI)

Stent Thrombosis2 year post-procedure

Stent thrombosis (per Academic Research Consortium (ARC) definition)

Stroke2 year post-procedure

Stroke

Target Lesion Failure2 year post-procedure

Defined as cardiac death, target vessel myocardial infarction (Q wave and non Q wave), or clinically driven target lesion revascularization(TLR) by percutaneous or surgical methods

Bleeding2 year post-procedure

Bleeding per BARC criteria

Revascularization2 year post-procedure

All revascularizations (TLR, TVR and non-TVR)

Procedure Success2 year post-procedure

Attainment of \<30% residual stenosis by QCA (or \<20% by visual assessment) AND TIMI flow 3 after the procedure, using any percutaneous method without the occurrence of MACE during the hospital stay.

Device success2 year post-procedure

Attainment of \<30% residual stenosis by QCA (or \<20% by visual assessment) AND TIMI flow 3 after the procedure, using the assigned device only.

Lesion Success2 year post-procedure

The attainment of \<30% residual stenosis by QCA (or \< 20% by visual assessment) AND TIMI flow 3 after the procedure, using any percutaneous method

Trial Locations

Locations (87)

Karolinska University Hospital in Solna

🇸🇪

Stockholm, Sweden

Södersjukhuset

🇸🇪

Stockholm, Sweden

Västmanlands Sjukhus

🇸🇪

Västerås, Sweden

Inselspital - Universitätsspital Bern

🇨🇭

Bern, Switzerland

Cardiocentro Ticino

🇨🇭

Lugano, Switzerland

Siriraj Hospital

🇹🇭

Bangkok, Thailand

Cardiff and Vale University Health Board - University Hospital of Wales (UHW)

🇬🇧

Cardiff, United Kingdom

Royal Infirmary of Edinburgh

🇬🇧

Edinburgh, United Kingdom

Royal Devon and Exeter NHS Foundation Trust

🇬🇧

Exeter, United Kingdom

Royal Free Hospital

🇬🇧

London, United Kingdom

Golden Jubilee National Hospital - NHS Trust

🇬🇧

Glasgow, United Kingdom

The James Cook University Hospital - South Tees Hospitals NHS

🇬🇧

Middlesbrough, United Kingdom

The Newcastle upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital

🇬🇧

Newcastle Upon Tyne, United Kingdom

Queen Alexandra Hospital

🇬🇧

Portsmouth, United Kingdom

Azienda Ospedaliera Bolognini Seriate - Ospedale Bolognini

🇮🇹

Seriate, Bergamo, Italy

Saint Vincent's Hospital (Melbourne)

🇦🇺

Fitzroy, Victoria, Australia

Fiona Stanley Hospital

🇦🇺

Murdoch, Western Australia, Australia

LKH - Universitätsklinikum Graz

🇦🇹

Graz, Austria

The Prince Charles Hospital

🇦🇺

Chermside, Queensland, Australia

Cairns Hospital

🇦🇺

Cairns, Queensland, Australia

Adelaide Cardiology

🇦🇺

Adelaide, South Australia, Australia

Bundaberg Cardiology - Friendly Society Private Hospital

🇦🇺

Bundaberg, Queensland, Australia

Royal North Shore Hospital

🇦🇺

Saint Leonards, New South Wales, Australia

Royal Brisbane and Women's Hospital

🇦🇺

Brisbane, Queensland, Australia

Princess Alexandra Hospital

🇦🇺

Woolloongabba, Queensland, Australia

Flinders Medical Centre

🇦🇺

Bedford Park, South Australia, Australia

The Alfred Hospital

🇦🇺

Melbourne, Victoria, Australia

UZ Leuven - Campus Gasthuisberg

🇧🇪

Leuven, Belgium

A.ö. Landeskrankenhaus - Universitätskliniken Innsbruck

🇦🇹

Innsbruck, Austria

C.H.U. de Charleroi

🇧🇪

Charleroi, Belgium

Allgemeines Krankenhaus - Universitätskliniken Wien

🇦🇹

Wien, Austria

CHU de Liège - Hôpital du Sart Tilman

🇧🇪

Liège, Belgium

Acibadem City Clinic

🇧🇬

Sofia, Bulgaria

Queen Elizabeth Hospital (Hong Kong)

🇭🇰

Hong Kong, Hong Kong

Queen Mary Hospital

🇭🇰

Hong Kong, Hong Kong

Hôpital Privé Jacques Cartier

🇫🇷

Massy, France

San Raffaele Scientific Institute

🇮🇹

Milano, Italy

Galway University Hospitals - University Hospital Galway (UHG)

🇮🇪

Galway, Ireland

Clinique Axium

🇫🇷

Aix-en-Provence, France

Umberto I - Policlinico di Roma

🇮🇹

Roma, Italy

Presidio Ospedaliero Ferrarotto Alessi

🇮🇹

Catania, Italy

Chonnam National University Hospital

🇰🇷

Gwangju, Korea, Republic of

Centro Cardiologico Monzino

🇮🇹

Milano, Italy

Keimyung University Dongsan Medical Center

🇰🇷

Daegu, Korea, Republic of

Seoul National University Bundang Hospital

🇰🇷

Seongnam-si, Korea, Republic of

Seoul Saint Mary's Hospital

🇰🇷

Seoul, Korea, Republic of

Wonju Severance Christian Hospital

🇰🇷

Wonju, Korea, Republic of

Paula Stradina Kliniska universitates slimnica

🇱🇻

Riga, Latvia

Hospital of Lithuanian University of Health Sciences Kauno Klinikos

🇱🇹

Kaunas, Lithuania

Vilnius University Hospital Santariskiu Klinikos

🇱🇹

Vilnius, Lithuania

Riga East University Hospital

🇱🇻

Riga, Latvia

Hospital Serdang

🇲🇾

Kajang, Selangor Darul Ehsan, Malaysia

Sarawak Heart Centre

🇲🇾

Kota Kinabalu, Malaysia

Queen Elizabeth II Hospital

🇲🇾

Kota Kinabalu, Sabah, Malaysia

Institut Jantung Negara - National Heart Institute

🇲🇾

Kuala Lumpur, Malaysia

Zuyderland Medisch Centrum Heerlen

🇳🇱

Heerlen, Netherlands

HagaZiekenhuis - Locatie Leyweg

🇳🇱

Den Haag, Netherlands

Universitair Medisch Centrum Groningen

🇳🇱

Groningen, Netherlands

Maastricht Universitair Medisch Centrum (MUMC)

🇳🇱

Maastricht, Netherlands

St. Antonius Ziekenhuis

🇳🇱

Nieuwegein, Netherlands

Isala Zwolle

🇳🇱

Zwolle, Netherlands

VieCuri Medisch Centrum voor Noord-Limburg - Locatie Venlo

🇳🇱

Venlo, Netherlands

Auckland City Hospital

🇳🇿

Auckland, New Zealand

Waikato Hospital

🇳🇿

Hamilton, New Zealand

Wellington Hospital

🇳🇿

Newtown, New Zealand

Oslo Universitetssykehus-Ullevål Universitetssykehus

🇳🇴

Oslo, Norway

Stavanger Universitetssjukehus - Helse Stavanger HF

🇳🇴

Stavanger, Norway

Górnośląskie Centrum Medyczne im prof Leszka Gieca Śląskiego Uniwersytetu Medycznego w Katowicach

🇵🇱

Katowice, Poland

Tan Tock Seng Hospital

🇸🇬

Singapore, Singapore

Miedziowe Centrum Zdrowia

🇵🇱

Lubin, Poland

National University Hospital

🇸🇬

Singapore, Singapore

Hospital Clínico Universitario Virgen de la Arrixaca

🇪🇸

El Palmar, Murcia, Spain

Hospital General Universitario de Alicante

🇪🇸

Alicante, Spain

Hospital Universitari Bellvitge

🇪🇸

Barcelona, Spain

Hospital Universitario La Paz

🇪🇸

Madrid, Spain

Hospital Universitario de Canarias

🇪🇸

La Laguna, Tenerife, Spain

Hospital del Mar

🇪🇸

Barcelona, Spain

Hospital Clinico Universitario de Salamanca

🇪🇸

Salamanca, Spain

Gävle sjukhus

🇸🇪

Gävle, Sweden

Hospital Universitario Marques de Valdecilla

🇪🇸

Santander, Spain

Severance Hospital

🇰🇷

Seoul, Korea, Republic of

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

Szpital Kliniczny Przemienienia Panskiego

🇵🇱

Poznań, Poland

Stredoslovensky Ustav Srdcovych a Cievnych Chorob a.s

🇸🇰

Banska Bystrica, Slovakia

Universitetssjukhuset Örebro

🇸🇪

Örebro, Sweden

© Copyright 2025. All Rights Reserved by MedPath